Dossier
Semax
Coverage of Semax in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
An FDA advisory panel recommended allowing compounding pharmacies to manufacture peptides epitalon and semax but voted against emideltide. Amgen is challenging the FDA's proposal to withdraw its drug Tavneos from the U.S. market, citing new evidence from over 70 real-world studies.
- Peptide Therapy for Brain Health: Supporting Focus, Memory, and Mental Energy as You Age
The article discusses peptide therapy for cognitive health, highlighting peptides like Semax, Selank, and CJC-1295/Ipamorelin as potential supports for mental clarity, focus, and stress resilience. Rejuvime Medical, a sponsor, emphasizes personalized protocols to address age-related cognitive decline and brain fog through targeted peptide interventions.